Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$36.025
Market cap
$18.38B
P/E Ratio
7.37
Dividend/share
$1.16
EPS
$4.89
Enterprise value
$29.63B
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating
Highlights
Baxter International's debt has decreased by 21% YoY and by 6% from the previous quarter
The gross profit has grown by 12% year-on-year and by 6% since the previous quarter
BAX's net income has surged by 187% year-on-year but it is down by 7% since the previous quarter
The EPS has soared by 187% YoY but it has contracted by 7% from the previous quarter
Key stats
What are the main financial stats of BAX
Market
Valuations
Earnings
Shares outstanding
510.18M
Market cap
$18.38B
Enterprise value
$29.63B
Price to book (P/B)
2.4
Price to sales (P/S)
1.23
EV/EBIT
10.17
EV/EBITDA
7.1
EV/Sales
1.98
Revenue
$15B
EBIT
$2.91B
EBITDA
$4.17B
Free cash flow
$511M
Per share
Balance sheet
Liquidity
EPS
$4.89
Free cash flow per share
$1
Book value per share
$15
Revenue per share
$29.41
TBVPS
$28.57
Total assets
$26.31B
Total liabilities
$18.6B
Debt
$13.34B
Equity
$7.64B
Working capital
$2.46B
Debt to equity
1.75
Current ratio
1.4
Quick ratio
0.77
Net debt/EBITDA
2.7
Margins
Efficiency
Dividend
EBITDA margin
27.8%
Gross margin
36.1%
Net margin
16.5%
Operating margin
1.8%
Return on assets
8.8%
Return on equity
30.6%
Return on invested capital
14%
Return on capital employed
14.4%
Return on sales
19.4%
Dividend yield
3.22%
DPS
$1.16
Payout ratio
23.7%
BAX stock price
How has the Baxter International stock price performed over time
Intraday
0.1%
1 week
-1.22%
1 month
-5.12%
1 year
12.44%
YTD
-6.82%
QTD
-5.12%
Financial performance
How have Baxter International's revenue and profit performed over time
Revenue
$15B
Gross profit
$5.41B
Operating income
$273M
Net income
$2.48B
Gross margin
36.1%
Net margin
16.5%
BAX's net income has surged by 187% year-on-year but it is down by 7% since the previous quarter
Baxter International's net margin has soared by 184% YoY but it has decreased by 7% from the previous quarter
The operating margin has soared by 111% YoY but it has decreased by 40% from the previous quarter
Baxter International's operating income has soared by 111% YoY but it has decreased by 39% from the previous quarter
Growth
What is Baxter International's growth rate over time
Valuation
What is Baxter International stock price valuation
P/E
7.37
P/B
2.4
P/S
1.23
EV/EBIT
10.17
EV/EBITDA
7.1
EV/Sales
1.98
The EPS has soared by 187% YoY but it has contracted by 7% from the previous quarter
BAX's P/B is 43% below its 5-year quarterly average of 4.2
The company's equity rose by 37% YoY but it fell by 6% QoQ
BAX's P/S is 53% below its 5-year quarterly average of 2.6 and 6% below its last 4 quarters average of 1.3
The revenue is up by 2.9% year-on-year
Efficiency
How efficient is Baxter International business performance
The ROA has soared by 186% YoY but it has contracted by 4.3% from the previous quarter
The company's return on equity has surged by 161% YoY but it fell by 13% QoQ
The ROS has contracted by 6% from the previous quarter
Dividends
What is BAX's dividend history
DPS
$1.16
Dividend yield
3.22%
Payout ratio
23.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Baxter International financials performed over time
The total assets is 41% more than the total liabilities
The total liabilities has decreased by 16% YoY and by 4.9% from the previous quarter
The quick ratio is down by 11% since the previous quarter but it is up by 5% year-on-year
Baxter International's debt is 75% more than its equity
The debt to equity has declined by 42% year-on-year
The company's equity rose by 37% YoY but it fell by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.